Richard Burack, MD, PhD, Associate Professor. Director of Hematopathology Unit, Flow Cytometry Laboratory, Protein Electrophoresis Laboratory, and the Molecular Genetic Pathology Unit. Dr. Burack initiated this fellowship program in 2007 after arriving from Washington University in St. Louis where he trained and ultimately ran the hematopathology fellowship there. Dr. Burack’s clinical practice is focused on the diagnosis of hematopoietic malignancies. He has a particular interest in the application of molecular methods to diagnosis of lymphoma.
John M. Bennett, MD, Professor Emeritus of Medicine, Pathology, and Laboratory Medicine. Dr. Bennett is an internationally renowned morphologist who has been instrumental in almost every aspect of marrow morphology. He played a critical role in the development of the FAB system for classification of AML and MDS, and continues as a contributor to the WHO system. In June 2013, Dr. Bennett completed his 20 year’s as an Editor-in-chief of “Leukemia Research”. Dr. Bennett also maintains a very substantial role in clinical conferences, is daily available for consultation, is directly involved in resident/fellow education. He also maintains a large consultation practice, including centralized review for clinical trials, which forms a great resource for fellow education.
Andrew Evans, MD, PhD, Assistant Professor, Pathology and Laboratory Medicine, Dr. Evans is the Hematopathology Fellowship Program Director. He joined the faculty in 2013 after completing his training in Boston at Brigham and Women’s Hospital, Harvard Medical School, and the Dana Farber Cancer Institute where he served as Chief Resident in Anatomic Pathology and completed his fellowship in Hematopathology. Dr. Evans earned his MD and PhD in Immunology and Molecular Pathogenesis from Emory University’s School of Medicine. Dr. Evans contributes to all aspects of the clinical hematopathology service, and his research interests include the immunology and pathobiology of lymphoproliferative disorders.
Archibald S. Perkins MD, PhD, Professor. Dr. Perkins joined the faculty in July 2007 having been on the faculty of the Dept. of Pathology of Yale University for 15 years. In addition to sign out responsibilities, Dr. Perkins has a substantial research program dedicated to the understanding of EVI1 (3q26) lesions in myeloid malignancies.
Daniel H. Ryan, MD, Professor Emeritus and past department chair. Dr. Ryan has been a practicing hematopathologist for almost 30 years with a long term research interest in hematopoiesis and the application of flow cytometry to studying hematopoiesis. He currently serves as the director of UR Central Labs.